Wang L P, Deng W P, Jia T W, Qin Z Q, Xu J
National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research); NHC Key Laboratory of Parasite and Vector Biology; WHO Collaborating Centre for Tropical Diseases; National Center for International Research on Tropical Diseases, Shanghai 200025, China.
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2021 Apr 20;33(2):138-147. doi: 10.16250/j.32.1374.2020321.
To evaluate the conversion of serum antibodies against in humans and livestock detected by immunological tests following treatment with praziquantel.
The studies pertaining to serological tests of schistosomiasis japonica published from 1991 to 2020 were retrieved in electronic databases, including Chinese National Knowledge Infrastructure, WanFang Data, PubMed and ScienceDirect. Data were extracted from included studies. The publication bias was assessed with funnel plots using the software RevMan version 5.3, and the conversion of antibodies against was evaluated through meta-analysis.
A total of 40 publications were included in the final meta-analysis, consisting of 33 Chinese publications and 7 English publications, and all immunological tests were performed with indirect hemagglutination test (IHA) and enzyme-linked immunosorbent assay (ELISA). Pooled analysis showed that the negative rates of serum anti- antibody were 45.36% [95% confidential interval (): (43.96%, 46.76%)] and 20.83% [95% : (19.69%, 21.97%)] detected by ELISA and IHA within 6 months post praziquantel treatment, 62.95% [95% : (61.59%, 64.31%)] and 55.61% [95% : (54.21%, 57.01%)] within 6 to 12 months after treatment and 85.92% [95% : (84.94%, 86.90%)] and 86.90% [95% : (85.95%, 87.85%)] over 12 months after treatment, respectively.
The negative rate of the serum anti- antibody by IHA and ELISA increased with the time of post-treatment with praziquantel. The overall negative rates of anti- antibody detected by IHA and ELISA are low within 12 months post praziquantel treatment. However, a high negative rate of anti- antibody is detected if there is no new contact with infested water after 12 months of praziquantel treatment.
评估吡喹酮治疗后通过免疫检测法检测的人和家畜血清中抗[具体寄生虫名称未给出]抗体的转阴情况。
检索1991年至2020年发表的关于日本血吸虫病血清学检测的研究,电子数据库包括中国知网、万方数据、PubMed和ScienceDirect。从纳入研究中提取数据。使用RevMan 5.3软件通过漏斗图评估发表偏倚,并通过荟萃分析评估抗[具体寄生虫名称未给出]抗体的转阴情况。
最终的荟萃分析共纳入40篇出版物,其中中文出版物33篇,英文出版物7篇,所有免疫检测均采用间接血凝试验(IHA)和酶联免疫吸附测定(ELISA)。汇总分析显示,吡喹酮治疗后6个月内,ELISA和IHA检测的血清抗[具体寄生虫名称未给出]抗体阴性率分别为45.36% [95%置信区间(CI):(43.96%,46.76%)]和20.83% [95% CI:(19.69%,21.97%)];治疗后6至12个月分别为62.95% [95% CI:(61.59%,64.31%)]和55.61% [95% CI:(54.21%,57.01%)];治疗后12个月以上分别为85.92% [95% CI:(84.94%,86.90%)]和86.90% [95% CI:(85.95%,87.85%)]。
吡喹酮治疗后,IHA和ELISA检测的血清抗[具体寄生虫名称未给出]抗体阴性率随治疗后时间增加。吡喹酮治疗后12个月内,IHA和ELISA检测的抗[具体寄生虫名称未给出]抗体总体阴性率较低。然而,吡喹酮治疗12个月后,如果没有再次接触受感染水源,则抗[具体寄生虫名称未给出]抗体阴性率较高。